MPHASIS: Q4 CONS NET PROFIT 5.1B RUPEES VS 4.4B (QOQ) || Q4 REVENUE 42B RUPEES VS 40B (QOQ)

 29 Apr 2026 11:56 PM

MPHASIS: Q4 CONS NET PROFIT 5.1B RUPEES VS 4.4B (QOQ) || Q4 REVENUE 42B RUPEES VS 40B (QOQ)

MPHASIS: Q4 EBIT 6.5B RUPEES VS 6.1B (QOQ) || Q4 EBIT MARGIN 15.38% VS 15.21% (QOQ)

 29 Apr 2026 11:56 PM

MPHASIS: Q4 EBIT 6.5B RUPEES VS 6.1B (QOQ) || Q4 EBIT MARGIN 15.38% VS 15.21% (QOQ)

MPHASIS: CO BOARD RECOMMENDS FINAL DIVIDEND OF ₹62 PER SHARE

 29 Apr 2026 11:57 PM

MPHASIS: CO BOARD RECOMMENDS FINAL DIVIDEND OF ₹62 PER SHARE

Mphasis: CLSA on Mphasis Hold, Target Price Rs 2219 as inconsistent growth, high dependence on US BFSI, limited diversification, and leakage in base business offset deal wins, with stable mid-teen margins but limited operating leverage.

 25 Mar 2026 08:57 AM

Mphasis: CLSA on Mphasis Hold, Target Price Rs 2219 as inconsistent growth, high dependence on US BFSI, limited diversification, and leakage in base business offset deal wins, with stable mid-teen margins but limited operating leverage.

MPHASIS: Jefferies Downgrade MPHASIS to Hold, Target Price cut to Rs 2450 from Rs 3410

 23 Feb 2026 09:13 AM

MPHASIS: Jefferies Downgrade MPHASIS to Hold, Target Price cut to Rs 2450 from Rs 3410

Mphasis: Co Ceo Says - See AI Deals Stemming From Banking, Airlines And Healthcare

 23 Jan 2026 12:16 PM

Mphasis: Co Ceo Says - See AI Deals Stemming From Banking, Airlines And Healthcare

Mphasis: Nomura on Mphasis Neutral, target price Rs 2970

 23 Jan 2026 09:12 AM

Mphasis: Nomura on Mphasis Neutral, target price Rs 2970

Mphasis: HSBC on Mphasis Buy, target price Rs 3350

 23 Jan 2026 09:12 AM

Mphasis: HSBC on Mphasis Buy, target price Rs 3350

Mphasis: Jefferies on Mphasis Buy, target price Rs 3410

 23 Jan 2026 09:12 AM

Mphasis: Jefferies on Mphasis Buy, target price Rs 3410

Mphasis: Motilal Oswal on Mphasis Maintain BUY with a target price of ₹3,900

 23 Jan 2026 09:12 AM

Mphasis: Motilal Oswal on Mphasis Maintain BUY with a target price of ₹3,900

Mphasis: Guidance - Management expects Q4 FY26 to be the strongest sequential growth quarter for the year, aligning with their guidance of achieving greater than 2x industry growth.- Concall Update

 23 Jan 2026 08:51 AM

Mphasis: Guidance - Management expects Q4 FY26 to be the strongest sequential growth quarter for the year, aligning with their guidance of achieving greater than 2x industry growth.- Concall Update

Mphasis: Guidance - The pace of revenue and deal conversion is expected to remain strong, propelled by the Savings-Led Transformation theme, with the direct business trending towards double-digit growth.- Concall Update

 23 Jan 2026 08:51 AM

Mphasis: Guidance - The pace of revenue and deal conversion is expected to remain strong, propelled by the Savings-Led Transformation theme, with the direct business trending towards double-digit growth.- Concall Update

Mphasis: Guidance - DSO is expected to trend progressively down over the course of the 2026 calendar year, and the EBIT margin will be maintained within the 14.75% to 15.75% band.- Concall Update

 23 Jan 2026 08:51 AM

Mphasis: Guidance - DSO is expected to trend progressively down over the course of the 2026 calendar year, and the EBIT margin will be maintained within the 14.75% to 15.75% band.- Concall Update

Mphasis: Guidance - While a detailed FY27 outlook will be provided in the April call, management anticipates the current growth template, observed over the last three quarters, will continue into FY27.- Concall Update

 23 Jan 2026 08:51 AM

Mphasis: Guidance - While a detailed FY27 outlook will be provided in the April call, management anticipates the current growth template, observed over the last three quarters, will continue into FY27.- Concall Update

Mphasis: Guidance - Overall tech spending is expected to be stable to slightly up this year, with a reprioritization of funds towards investing in AI fabric, and BFSI is projected to remain a leading growth vertical.- Concall Update

 23 Jan 2026 08:51 AM

Mphasis: Guidance - Overall tech spending is expected to be stable to slightly up this year, with a reprioritization of funds towards investing in AI fabric, and BFSI is projected to remain a leading growth vertical.- Concall Update

Mphasis: Company Reports Revenue Increase Of 2.6% QOQ And 12.4% YOY In Q3 FY26 On Reported Basis, With Constant Currency Growth Of 1.5% QOQ And 7.4% YOY. Direct Revenue Also Rises By 3.1% QOQ And 15.9% YOY In Reported Basis; Grows 1.9% QOQ And 9.6% YOY In Constant Currency

 22 Jan 2026 07:43 PM

Mphasis: Company Reports Revenue Increase Of 2.6% QOQ And 12.4% YOY In Q3 FY26 On Reported Basis, With Constant Currency Growth Of 1.5% QOQ And 7.4% YOY. Direct Revenue Also Rises By 3.1% QOQ And 15.9% YOY In Reported Basis; Grows 1.9% QOQ And 9.6% YOY In Constant Currency

MPHASIS: Q3 CONS NET PROFIT 4.4B RUPEES VS 4.69B (QOQ); EST 4.77B || Q3 REVENUE 40B RUPEES VS 39B (QOQ); EST 40.15B

 22 Jan 2026 05:18 PM

MPHASIS: Q3 CONS NET PROFIT 4.4B RUPEES VS 4.69B (QOQ); EST 4.77B || Q3 REVENUE 40B RUPEES VS 39B (QOQ); EST 40.15B

MPHASIS: Q3 EBIT 6.1B RUPEES VS 6B (QOQ); EST 6.07B || Q3 EBIT MARGIN 15.21% VS 15.3% (QOQ); EST 15.3%

 22 Jan 2026 05:20 PM

MPHASIS: Q3 EBIT 6.1B RUPEES VS 6B (QOQ); EST 6.07B || Q3 EBIT MARGIN 15.21% VS 15.3% (QOQ); EST 15.3%

Mphasis: Company Acquires Full 49% Stake In Mrald Limited, UK, Making It A Complete Subsidiary

 17 Jan 2026 04:31 PM

Mphasis: Company Acquires Full 49% Stake In Mrald Limited, UK, Making It A Complete Subsidiary

Mphasis: Citi on Mphasis Maintain Neutral with ticket price of Rs 2905 vs 2780

 02 Jan 2026 09:09 AM

Mphasis: Citi on Mphasis Maintain Neutral with ticket price of Rs 2905 vs 2780